Israeli medical expert addresses UK audience

[Behind the Aegis]

Leading figures from the medical and pharmaceutical world attended a breakfast meeting in central London last week to hear Professor Moussa Youdim, director of the Eve Topf Neurodegenerative Diseases Centre at the Technion, Haifa and a world-renowned expert in the development of drugs to treat Alzheimer’s and Parkinson’s disease.

The event, hosted by law firm Mishcon de Reya, had a live video link-up to Prof Youdim in Israel. Professionals from hospitals across London as well as research universities and leading pharmaceutical companies took part in the round table discussion.

Rare discovery

Prof Youdim talked about his discovery of Rasagiline, a new drug which marks a major breakthrough in the treatment of Parkinson’s disease. The drug was made available in the UK last year by Teva Pharmaceuticals, under the brand name Azilect.

In a study of 687 Parkinson’s patients from Israel, Argentina and Europe, Azilect and Entracapone were compared when used with the drug Levodopa.

more...

[GeorgeGist]

1. I think you'd get more hits if you changed your subject line...

to reflect the breakthrough. Interesting article.